Company: GANX
Filing Date: 2025-02-06
Form Type: 8-K
Source: 0001104659-25-010148
Chunk: 0

Company: Gain Therapeutics, Inc.
Filing Date: 2025-02-06
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

On February 6, 2025, Gain
Therapeutics, Inc. (the “ Company”) issued a press release providing an operational update. A copy of the press release is
furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The
information in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished
to the Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, and shall
not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by a specific reference in such filing.